Worth reading
39Recurring
Scored from 4 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Who is moving to which position
Resolved 25 September 2026Incoming appointee
6 itemsScheduled Appointment Date1 October 2026
Fujimune Tadahiko (藤宗 忠彦)
Previous positionHead of the Regulatory Affairs Department, Regulatory Affairs and Development Division
New positionExecutive Officer and Head of the Regulatory Affairs and Development Division
Minamiya Hiroyuki (南谷 浩之)
Previous positionCEO, Ortho Development Corporation (secondment)
New positionExecutive Officer and CEO, Ortho Development Corporation (secondment)
Nagataka Masato (長髙 正人)
Previous positionHead of the Business Development Office, Corporate Strategy Division
New positionHead of the Corporate Planning Department, Corporate Strategy Division
Ikeda Mitsunari (池田 光成)
Previous positionSenior Manager, Corporate Planning Department, Corporate Strategy Division
New positionHead of the FP&A Department, Corporate Strategy Division
Miura Takashi (三浦 高)
Previous positionManager, Development and Manufacturing Department, Regulatory Affairs and Development Division
New positionHead of the Business Development Office, Business Division
Inoue Masato (井上 真人)
Previous positionSenior Manager, Regulatory Affairs Department, Regulatory Affairs and Development Division
New positionHead of the Regulatory Affairs Department, Regulatory Affairs and Development Division
Departing officer
1 itemDate of departure30 September 2026
Miyata Shinichi (宮田 伸一)Stepping down
Former PositionExecutive Officer and Head of the Regulatory Affairs and Development Division
Reason for change
To respond to changes in the business environment, achieve sustainable growth and strengthen the earnings base, the Company will develop an organizational structure that enables it to steadily advance reforms to its earnings structure.
Details of organizational changes
Establishment of an FP&A Department within the Corporate Strategy Division, Transfer of the Business Development Office from the Corporate Strategy Division to the Business Division
| Item | Details |
|---|---|
| Resolution date | 25 September 2026 |
| Scheduled Appointment Date | 1 October 2026 |
| Date of departure | 30 September 2026 |
| Name of appointee | Fujimune Tadahiko (藤宗 忠彦), Minamiya Hiroyuki (南谷 浩之), Nagataka Masato (長髙 正人), Ikeda Mitsunari (池田 光成), Miura Takashi (三浦 高), Inoue Masato (井上 真人) |
| Appointee's new position | Executive Officer and Head of the Regulatory Affairs and Development Division, Executive Officer and CEO, Ortho Development Corporation (secondment), Head of the Corporate Planning Department, Corporate Strategy Division, Head of the FP&A Department, Corporate Strategy Division, Head of the Business Development Office, Business Division, Head of the Regulatory Affairs Department, Regulatory Affairs and Development Division |
| Appointee's previous position | Head of the Regulatory Affairs Department, Regulatory Affairs and Development Division, CEO, Ortho Development Corporation (secondment), Head of the Business Development Office, Corporate Strategy Division, Senior Manager, Corporate Planning Department, Corporate Strategy Division, Manager, Development and Manufacturing Department, Regulatory Affairs and Development Division, Senior Manager, Regulatory Affairs Department, Regulatory Affairs and Development Division |
| Name of departing officer | Miyata Shinichi (宮田 伸一) |
| Former position of departing officer | Executive Officer and Head of the Regulatory Affairs and Development Division |
| Reason for change | To respond to changes in the business environment, achieve sustainable growth and strengthen the earnings base, the Company will develop an organizational structure that enables it to steadily advance reforms to its earnings structure. |
| Details of organizational changes | Establishment of an FP&A Department within the Corporate Strategy Division, Transfer of the Business Development Office from the Corporate Strategy Division to the Business Division |
Items this document does not state (11)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeNew position of departing officerReason for departureWhether the incumbent will remain in officeReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To respond to changes in the business environment, achieve sustainable growth and strengthen the earnings base, the Company will clarify the roles of the corporate planning and FP&A functions to improve the quality and speed of management decision-making, and strengthen execution capabilities by reorganizing the business development function.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.